Evidence map›Paper›PMID 25400038›Full record

ArticleNature communications2014

Omega-1 knockdown in Schistosoma mansoni eggs by lentivirus transduction reduces granuloma size in vivo.

Jana Hagen, Neil D Young, Alison L Every, Charles N Pagel, Corinna Schnoeller, Jean-Pierre Y Scheerlinck, Robin B Gasser, Bernd H Kalinna

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 71 citations in OpenAlex.

  1. TrueFrontiers in cellular and infection microbiology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Trematode Genomics and Proteomics.Advances in experimental medicine and biology · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Measuring the Manipulation of T Helper Immune Responses byInternational journal of molecular sciences · 2022
    Article
  12. Schistosome immunomodulators.PLoS pathogens · 2021
    Review
  13. The Transcriptome ofFrontiers in tropical diseases · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Biomphalaria glabrata immunity: Post-genome advances.Developmental and comparative immunology · 2020
    Review
  19. AdjuvantedFrontiers in immunology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jana HagenFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.
Neil D YoungFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.
Alison L EveryFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.
Charles N PagelFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.
Corinna SchnoellerDepartment of Life Sciences, Imperial College London, London SW7 2AZ, UK.
Jean-Pierre Y ScheerlinckFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.
Robin B GasserFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.
Bernd H KalinnaFaculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.
University of Melbourne · AUImperial College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis, one of the most important neglected tropical diseases worldwide, is caused by flatworms (blood flukes or schistosomes) that live in the bloodstream of humans. The hepatointestinal form of this debilitating disease results from a chronic infection with Schistosoma mansoni or Schistosoma japonicum. No vaccine is available to prevent schistosomiasis, and treatment relies predominantly on the use of a single drug, praziquantel. In spite of considerable research effort over the years, very little is known about the complex in vivo events that lead to granuloma formation and other pathological changes during infection. Here we use, for the first time, a lentivirus-based transduction system to deliver microRNA-adapted short hairpin RNAs (shRNAmirs) into the parasite to silence and explore selected protein-encoding genes of S. mansoni implicated in the disease process. This gene-silencing system has potential to be used for functional genomic-phenomic studies of a range of socioeconomically important pathogens.

Indexed as

AnimalsAntigens, HelminthEgg ProteinsEggsGene Knockdown TechniquesGene SilencingGranulomaLentivirusMice, Inbred BALB CMicroRNAsRNA, Small InterferingSchistosoma mansoniSchistosomiasis mansoniTransduction, GeneticAntigens, HelminthEgg ProteinsMicroRNAsomega-1 antigen, Schistosoma mansoniRNA, Small Interfering

Identifiers

PMID25400038
PMCPMC4243216
OpenAlexW2086671079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.